• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病与 SARS-CoV-2:宿主免疫反应与病毒直接损伤的作用。

Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.

机构信息

Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Internal Medicine and Vascular Diseases Unit, 00168 Roma, Italy.

出版信息

Int J Mol Sci. 2020 Oct 30;21(21):8141. doi: 10.3390/ijms21218141.

DOI:10.3390/ijms21218141
PMID:33143371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7663579/
Abstract

The 2019 novel coronavirus [2019-nCoV], which started to spread from December 2019 onwards, caused a global pandemic. Besides being responsible for the severe acute respiratory syndrome 2 [SARS-CoV-2], the virus can affect other organs causing various symptoms. A close relationship between SARS-CoV-2 and the cardiovascular system has been shown, demonstrating an epidemiological linkage between SARS-CoV-2 and cardiac injury. There are emerging data regarding possible direct myocardial damage by 2019-nCoV. In this review, the most important available evidences will be discussed to clarify the precise mechanisms of cardiovascular injury in SARS-CoV-2 patients, even if further researches are needed.

摘要

自 2019 年 12 月开始传播的 2019 年新型冠状病毒(2019-nCoV)引发了全球大流行。除了引发严重急性呼吸系统综合征 2(SARS-CoV-2)外,该病毒还可影响其他器官导致各种症状。SARS-CoV-2 与心血管系统的关系密切,表明 SARS-CoV-2 与心脏损伤之间存在流行病学联系。目前有关于 2019-nCoV 可能直接导致心肌损伤的新数据。在这篇综述中,将讨论最重要的现有证据,以阐明 SARS-CoV-2 患者心血管损伤的确切机制,尽管还需要进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f5/7663579/a3b999ab4ab7/ijms-21-08141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f5/7663579/a3b999ab4ab7/ijms-21-08141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f5/7663579/a3b999ab4ab7/ijms-21-08141-g001.jpg

相似文献

1
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.心血管疾病与 SARS-CoV-2:宿主免疫反应与病毒直接损伤的作用。
Int J Mol Sci. 2020 Oct 30;21(21):8141. doi: 10.3390/ijms21218141.
2
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
3
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.SARS-CoV-2 感染患者的直接或间接肝损伤。
Semin Liver Dis. 2020 Aug;40(3):321-330. doi: 10.1055/s-0040-1715108. Epub 2020 Sep 4.
4
COVID-19 associated viral myocarditis: does it exist?新型冠状病毒肺炎相关的病毒性心肌炎:它存在吗?
Monaldi Arch Chest Dis. 2020 Sep 9;90(4). doi: 10.4081/monaldi.2020.1382.
5
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体多次检测不到的新型冠状病毒肺炎(COVID-19)患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
6
[The Peripheral Neuropathy and Myopathy Associated with Severe Acute Respiratory Syndrome-Correlated New Coronavirus (SARS-Cov-2)].[与严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)相关的周围神经病和肌病]
Brain Nerve. 2020 Oct;72(10):1045-1048. doi: 10.11477/mf.1416201646.
7
Pathogenic mechanisms of cardiovascular damage in COVID-19.COVID-19 中心血管损伤的发病机制。
Mol Med. 2024 Jun 19;30(1):92. doi: 10.1186/s10020-024-00855-2.
8
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.COVID-19、肥大细胞、细胞因子风暴、心理压力和神经炎症。
Neuroscientist. 2020 Oct-Dec;26(5-6):402-414. doi: 10.1177/1073858420941476. Epub 2020 Jul 18.
9
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者:体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
10
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.CAPACITY-COVID:一项欧洲登记研究,旨在确定心血管疾病在新冠疫情中的作用。
Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.

引用本文的文献

1
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview.冠状病毒在人体内引发的直接、间接及感染后损伤:综述
Virusdisease. 2022 Dec;33(4):429-444. doi: 10.1007/s13337-022-00793-9. Epub 2022 Oct 25.
2
Cardiovascular Outcomes in the Acute Phase of COVID-19.COVID-19 急性期的心血管结局。
Int J Mol Sci. 2021 Apr 15;22(8):4071. doi: 10.3390/ijms22084071.

本文引用的文献

1
COVID-19 in people with diabetes: understanding the reasons for worse outcomes.COVID-19 与糖尿病:了解预后不佳的原因。
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792. doi: 10.1016/S2213-8587(20)30238-2. Epub 2020 Jul 17.
2
COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation.以Takotsubo心肌病合并心房颤动为表现的新型冠状病毒肺炎
Int J Cardiol Heart Vasc. 2020 Jul 10;29:100580. doi: 10.1016/j.ijcha.2020.100580. eCollection 2020 Aug.
3
Dexamethasone in Hospitalized Patients with Covid-19.
地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
SARS-CoV-2: An immunogenetics call to arms.SARS-CoV-2:免疫遗传学的宣战。
Int J Immunogenet. 2020 Aug;47(4):319-323. doi: 10.1111/iji.12504. Epub 2020 Jul 12.
5
A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients.人类白细胞抗原在移植患者中易感染 SARS-CoV-2 的易感性中的作用。
Int J Immunogenet. 2020 Aug;47(4):324-328. doi: 10.1111/iji.12505. Epub 2020 Jul 5.
6
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.SARS-CoV-2 与心血管并发症:从分子机制到药物治疗管理。
Biochem Pharmacol. 2020 Aug;178:114114. doi: 10.1016/j.bcp.2020.114114. Epub 2020 Jun 21.
7
SARS-CoV-2 infection-induced immune responses: Friends or foes?SARS-CoV-2 感染诱导的免疫反应:是敌是友?
Scand J Immunol. 2020 Aug;92(2):e12895. doi: 10.1111/sji.12895. Epub 2020 Jun 17.
8
Takotsubo Syndrome Associated with COVID-19.与新型冠状病毒肺炎相关的应激性心肌病
Eur J Case Rep Intern Med. 2020 Apr 21;7(5):001665. doi: 10.12890/2020_001665. eCollection 2020.
9
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].羟氯喹治疗中度新型冠状病毒肺炎患者的一项试点研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03.
10
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞:一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.